Advagene Biopharma Co., Ltd. (TPEX:6709)
31.00
-2.00 (-6.06%)
Mar 4, 2026, 1:47 PM CST
17.65% (1Y)
| Market Cap | 1.96B +60.2% |
| Revenue (ttm) | n/a |
| Net Income | -71.10M |
| EPS | -1.23 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 97,959 |
| Average Volume | 163,316 |
| Open | 32.00 |
| Previous Close | 33.00 |
| Day's Range | 30.90 - 33.10 |
| 52-Week Range | 15.75 - 41.00 |
| Beta | 0.78 |
| RSI | 55.76 |
| Earnings Date | Mar 20, 2026 |